Niche partitioning of a pathogenic microbiome driven by chemical gradients
暂无分享,去创建一个
Rob Knight | Pieter C. Dorrestein | Louis-Felix Nothias | James T. Morton | Alexey V. Melnik | Isaac Klapper | Gail Ackermann | Robert A. Quinn | Daniel Wangpraseurt | Tianyu Zhang | Ricardo da Silva | Alexander Aksenov | Douglas Conrad | R. Knight | P. Dorrestein | G. Ackermann | I. Klapper | D. Wangpraseurt | D. Conrad | A. Aksenov | A. Melnik | Tianyu Zhang | R. Quinn | R. D. da Silva | L. Nothias | William Comstock | Alda Tran | William Comstock | Alda Tran | R. Knight | Louis-Félix Nothias
[1] M. Welsh,et al. Reduced Airway Surface pH Impairs Bacterial Killing in the Porcine Cystic Fibrosis Lung , 2012, Nature.
[2] R. Hunter,et al. Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease , 2016, bioRxiv.
[3] Barbara A. Bailey,et al. Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome , 2015, The ISME Journal.
[4] D. Newman,et al. Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation , 2015, mBio.
[5] S. Lynch,et al. The cystic fibrosis airway microbiome. , 2013, Cold Spring Harbor perspectives in medicine.
[6] Richard C Boucher,et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.
[7] J. Clancy,et al. Nasal potential difference measurements to assess CFTR ion channel activity. , 2011, Methods in molecular biology.
[8] M. Kühl,et al. Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum , 2014, Front. Microbiol..
[9] M. Sánchez. Antibiotic resistance in the opportunistic pathogen Stenotrophomonas maltophilia , 2015, Front. Microbiol..
[10] P. Tulkens,et al. Aminoglycosides: Activity and Resistance , 1999, Antimicrobial Agents and Chemotherapy.
[11] Kristian Fog Nielsen,et al. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking , 2016, Nature Biotechnology.
[12] Jose A Navas-Molina,et al. Balance Trees Reveal Microbial Niche Differentiation , 2017, mSystems.
[13] U. Römling,et al. Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung. , 2005, Journal of medical microbiology.
[14] L. Hoffman,et al. Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onset , 2011, Expert review of molecular diagnostics.
[15] Jose A Navas-Molina,et al. Deblur Rapidly Resolves Single-Nucleotide Community Sequence Patterns , 2017, mSystems.
[16] Shibu Yooseph,et al. Meta-omics uncover temporal regulation of pathways across oral microbiome genera during in vitro sugar metabolism , 2015, The ISME Journal.
[17] Nuno Bandeira,et al. Interkingdom metabolic transformations captured by microbial imaging mass spectrometry , 2012, Proceedings of the National Academy of Sciences.
[18] Barbara A. Bailey,et al. A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation , 2015, The ISME Journal.
[19] Daniel G. Lee,et al. Pyocyanin Production by Pseudomonas aeruginosa Induces Neutrophil Apoptosis and Impairs Neutrophil-Mediated Host Defenses In Vivo1 , 2005, The Journal of Immunology.
[20] T. Fenchel,et al. Oxygen and the Spatial Structure of Microbial Communities , 2008, Biological reviews of the Cambridge Philosophical Society.
[21] Robert Schmieder,et al. Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2,3-butanedione fermentation , 2014, The ISME Journal.
[22] Nigel W. Hardy,et al. Proposed minimum reporting standards for chemical analysis , 2007, Metabolomics.
[23] Matej Oresic,et al. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data , 2010, BMC Bioinformatics.
[24] Sophie J. Weiss,et al. Correlation detection strategies in microbial data sets vary widely in sensitivity and precision , 2016, The ISME Journal.
[25] F. Rohwer,et al. Ecological networking of cystic fibrosis lung infections , 2016, npj Biofilms and Microbiomes.
[26] P. Salamon,et al. Cystic fibrosis therapy: a community ecology perspective. , 2013, American journal of respiratory cell and molecular biology.
[27] L. Rigottier-Gois,et al. Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis , 2013, The ISME Journal.
[28] A. Warris,et al. Aspergillus infections in cystic fibrosis. , 2016, The Journal of infection.
[29] S. Doucette,et al. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis , 2011, Thorax.
[30] K. Kerr,et al. Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients. , 2001, International journal of antimicrobial agents.
[31] D. Jahn,et al. Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung. , 2010, International journal of medical microbiology : IJMM.
[32] M. Whiteley,et al. Oxygen levels rapidly modulate Pseudomonas aeruginosa social behaviours via substrate limitation of PqsH , 2010, Molecular microbiology.
[33] Theodore Alexandrov,et al. 3D molecular cartography using LC–MS facilitated by Optimus and 'ili software , 2017, Nature Protocols.
[34] R. Knight,et al. Pyrosequencing-Based Assessment of Soil pH as a Predictor of Soil Bacterial Community Structure at the Continental Scale , 2009, Applied and Environmental Microbiology.
[35] W. Blankenfeldt,et al. Recent insights into the diversity, frequency and ecological roles of phenazines in fluorescent Pseudomonas spp. , 2013, Environmental microbiology.
[36] S. Garneau‐Tsodikova,et al. Cosubstrate Tolerance of the Aminoglycoside Resistance Enzyme Eis from Mycobacterium tuberculosis , 2012, Antimicrobial Agents and Chemotherapy.
[37] J. Lipuma,et al. Cystic fibrosis lung microbiome: Opportunities to reconsider management of airway infection , 2015, Pediatric pulmonology.
[38] Barbara A. Bailey,et al. Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease , 2014, The ISME Journal.
[39] J. Bargon,et al. Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients. , 1999, Respiratory medicine.
[40] M. Elkins,et al. Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolates Derived from Patients with Cystic Fibrosis under Aerobic, Anaerobic, and Biofilm Conditions , 2005, Journal of Clinical Microbiology.
[41] Forest Rohwer,et al. Biogeochemical Forces Shape the Composition and Physiology of Polymicrobial Communities in the Cystic Fibrosis Lung , 2014, mBio.
[42] M. Rogers,et al. Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis , 2018, PloS one.
[43] Nuno Bandeira,et al. Three-Dimensional Microbiome and Metabolome Cartography of a Diseased Human Lung. , 2017, Cell host & microbe.
[44] P. Meda,et al. Rhamnolipids Are Virulence Factors That Promote Early Infiltration of Primary Human Airway Epithelia by Pseudomonas aeruginosa , 2006, Infection and Immunity.
[45] M. Dworkin. Sergei Winogradsky: a founder of modern microbiology and the first microbial ecologist. , 2012, FEMS microbiology reviews.
[46] P. Ralph,et al. A split flow chamber with artificial sediment to examine the below-ground microenvironment of aquatic macrophytes , 2014 .
[47] J. Rello,et al. Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies* , 2009, Critical care medicine.
[48] P. Dorrestein,et al. The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections. , 2017, Journal of visualized experiments : JoVE.
[49] Pradeep K. Singh,et al. Cystic Fibrosis Sputum Supports Growth and Cues Key Aspects of Pseudomonas aeruginosa Physiology , 2005, Journal of bacteriology.